Clinical Trial Update: Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating testosterone replacement in male cancer survivors with fatigue and low testosterone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome
• Hypogonadism

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: Seattle Institute for Biomedical and Clinical Research | Conditions: Hypogonadism, Male, Fatigue Syndrome, Chronic | Phase 2 | Status: ACTIVE_NOT_RECRUITING